Last reviewed · How we verify
Influenza
Approved treatments
- Inavir · Daiichi Sankyo
- Vaccine Support Cp · Women and Infants Hospital of Rhode Island
- Test formulation (Treatment A) · Pfizer
- Hospital-Based Vaccination Pathway · Pfizer
- Xofluza · Roche
Xofluza works by inhibiting the endonuclease activity of the influenza virus's polymerase, preventing viral replication. - Formol
- PF-07836396 Influenza saRNA · Pfizer
- PF-07852352 Influenza saRNA 1 · Pfizer
- PF-07914705 Influenza saRNA · Pfizer
- PF-07836395 Influenza saRNA · Pfizer
- PF-07915048 Influenza saRNA · Pfizer
- Relenza · GSK
Relenza works by blocking the neuraminidase enzyme, preventing the influenza virus from spreading and infecting new cells. - Avigan · Toyama Chemical Co., Ltd.
- PF-07871987 Influenza saRNA · Pfizer
- PF-07836394 Influenza saRNA · Pfizer
- Arbidol · Zheng Liu
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape: